VERAVera Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Vera Therapeutics, Inc. against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VERAThis | $2.4B#3 | — | 6.0x#2 | — | — | -96.9%#4 | — | -73.5%#3 | -72.7%#1 | — | 37.4%#1 | — |
| SLS | $2.3B#4 | — | 16.9x#3 | — | -100.0%#3 | 13.0%#1 | — | -19.5%#2 | — | — | — | — |
| DNTH | $5.7B#2 | — | 4.8x#1 | 2790.7x#2 | -67.3%#2 | -91.1%#3 | -8739.3%#2 | -13.9%#1 | — | — | — | — |
| CYTK | $9.6B#1 | — | — | 109.4x#1 | 376.6%#1 | -33.2%#2 | -695.4%#1 | — | — | — | — | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice